from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1626/-

LFCtreatmentdescriptionclass of inhibitor

-0.904

Amikacinug/mL Amikacintranslation

-0.266

Cap5-10ug/mL Capreomycintranslation

0.325

Rox10-50 ug/mL Roxithromycintranslation

-0.400

SM2-5 ug/mL Streptomycintranslation

-0.468

Tet5-10 ug/mL Tetracyclinetranslation

-0.103

Rif0.2-5ug/mL Rifampicintranscription

-0.921

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.094

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.004

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.628

CPZ10-50 ug/mL Chlorpromazinerespiration

0.241

Clofazimine10-13 ug/mL Clofaziminerespiration

0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.696

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.040

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.320

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.296

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.512

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.939

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.791

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.760

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.462

KCN5-20 ug/mL Potassium cyaniderespiration

1.085

NaN30.2-2 mM Sodium aziderespiration

0.911

Nigericin50 uM Nigericinrespiration

-0.618

TRC10-150 ug/mL Triclosanrespiration

-2.577

TRZ10-25 ug/mL Thioridazinerespiration

-1.096

Valinomycin0.5-10 uM Valinomycinrespiration

0.614

ZnSO42 mM ZnSO4respiration

-0.611

menadione6-10 ug/mL Menadionerespiration

-0.284

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.403

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.792

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.573

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.114

NRP_1Non-replicating persistence stage 1dosRassociated

0.437

Amp0.2mg/mL AmpicillincellWall

0.267

Cephalexin20-100 ug/mL CephalexincellWall

-0.003

Cerulenin0.32-5 ug/mL CerulenincellWall

1.110

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.469

EMB10-20 ug/mL EthambutolcellWall

0.601

Eta12-40 ug/mL EthionamidecellWall

1.277

INH0.2-0.4 ug/mL IsoniazidcellWall

0.411

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.776

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.649

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.126

BZA0.12 mg/mL BenzamidearomaticAmides

-0.043

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.479

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.256

H2O24 mM hydrogen peroxideDNAdamaging

0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.747

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.986

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.463

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.130

UVUV-irradiationDNAdamaging

0.409

ARP41-4 ug/mL Antitubercular compound ARP4?

0.647

Antimycin12.5-50 ug/mL Antimycin A?

0.935

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.891

PA_110-50 ug/mL Antitubercular compound PA-1?

0.411

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.009

PA8240.2-2 ug/mL PA-824?

-0.592

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.060

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.599

Verapamil50 uM Verapamil?

0.719

mercaptoethanol2 mM 2-Mercaptoethanol?

0.245

methoxatin10-20 ug/mL Methoxatin?